ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,277 | +35.6% | 47,527 | +28.2% | 0.11% | +17.2% |
| Q1 2023 | $942 | -99.8% | 37,073 | +223.9% | 0.09% | +86.0% |
| Q3 2022 | $378,000 | -64.5% | 11,447 | -62.1% | 0.05% | -68.8% |
| Q2 2022 | $1,065,000 | +104.0% | 30,241 | +166.5% | 0.16% | +128.6% |
| Q1 2022 | $522,000 | +141.7% | 11,346 | +51.1% | 0.07% | +29.6% |
| Q1 2020 | $216,000 | -22.6% | 7,511 | +70.7% | 0.05% | +68.8% |
| Q4 2019 | $279,000 | +3.0% | 4,400 | -54.2% | 0.03% | -13.5% |
| Q3 2019 | $271,000 | -71.4% | 9,600 | -73.2% | 0.04% | -65.1% |
| Q2 2019 | $949,000 | -25.7% | 35,800 | -48.6% | 0.11% | -17.8% |
| Q1 2019 | $1,277,000 | +408.8% | 69,613 | +244.3% | 0.13% | +344.8% |
| Q4 2018 | $251,000 | -74.0% | 20,217 | -84.9% | 0.03% | -43.1% |
| Q1 2018 | $966,000 | – | 133,969 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,264 | $54,392,000 | 33.22% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $216,228,000 | 28.00% |
| L1 Capital Pty Ltd | 296,024 | $19,629,000 | 4.93% |
| Aquilo Capital Management, LLC | 407,926 | $27,050,000 | 4.89% |
| Evolutionary Tree Capital Management, LLC | 72,948 | $4,837,000 | 2.86% |
| ACUTA CAPITAL PARTNERS, LLC | 108,000 | $7,161,000 | 2.58% |
| First Light Asset Management, LLC | 536,836 | $35,598,000 | 2.36% |
| Parkman Healthcare Partners LLC | 70,089 | $4,648,000 | 1.08% |
| Hood River Capital Management LLC | 357,082 | $23,678,000 | 0.76% |
| Vanguard Capital Wealth Advisors | 11,099 | $703,565,000 | 0.60% |